Respiratory physician Lutz Beckert considers chronic obstructive pulmonary disease management, including the prevention of COPD, the importance of smoking cessation and pulmonary rehabilitation, and the lifesaving potential of addressing treatable traits. He also discusses the logic of inhaler therapy, moving from single therapy to dual and triple therapy when indicated, as well as other aspects of management
PrEP is coming to Aotearoa – a logical step to further reduce HIV transmission
+Print Archive
PRACTICE
PrEP is coming to Aotearoa – a logical step to further reduce HIV transmission
Wednesday 28 March 2018, 02:00 AM

In the absence of a vaccine or a cure, the traditional, condom-based prevention strategies seem unable to stem the HIV tide
Antiretroviral therapy use by an HIV-negative person is not new; post-exposure prophylaxis is common. Now, there is funding for pre-exposure prophylaxis in high-risk individuals. This article is a review of PrEP, as it applies locally, and of the role GPs can play
Key points, From 1 March, PrEP with tenofovir disoproxil fumarate/ emtricitabine has been approved by Pharmac for patients at high-risk of HIV transmission.
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.